TY - JOUR
T1 - Selective inhibition of ribosomal RNA synthesis in mammalian cells
AU - Tavitian, Armand
AU - Uretsky, Stanley C.
AU - Acs, George
N1 - Funding Information:
This study was aided by grant CA-o875I from the National Institutes of Health, by grant P-299 from the American Cancer Society, and by Muscular Dystrophy Associations of America.
Funding Information:
Abbreviations: rRNA, ribosomal RNA; tRNA, transfer RNA. * Career scientist of the French National Institute of Health and Medical Research, supported by a fellowship from the International Union Against Cancer (Eleanor Roosevelt Cancer Foundation).
PY - 1968/3/18
Y1 - 1968/3/18
N2 - 1. Toyocamycin, in low concentrations, completely inhibits 28-S and 18-S RNA synthesis; it permits, however, the synthesis of a normally methylated 45-S RNA that accumulates in the cells' nucleoli. This RNA contains toyocamycin. The cells resume rRNA synthesis after the removal of the antibiotic from the medium; the 45-S RNA synthesized in the presence of toyocamycin is not converted under these conditions into 28-S and 18-S RNA, whereas the normally pulse-labeled 45-S RNA is converted to rRNA regardless of the presence of toyocamycin. We postulate that the altered structure of the 45-S RNA does not permit this conversion. Synthesis of tRNA is not inhibited by toyocamycin, as shown by the ratio of methylation to nucleoside incorporation and the ratio of pseudo-uridine to uridine in the 4-S RNA that was synthesized in the presence of toyocamycin. 2. The concentration of toyocamycin that impairs RNA synthesis is cytotoxic, but permits normal DNA and protein synthesis for 6 h.
AB - 1. Toyocamycin, in low concentrations, completely inhibits 28-S and 18-S RNA synthesis; it permits, however, the synthesis of a normally methylated 45-S RNA that accumulates in the cells' nucleoli. This RNA contains toyocamycin. The cells resume rRNA synthesis after the removal of the antibiotic from the medium; the 45-S RNA synthesized in the presence of toyocamycin is not converted under these conditions into 28-S and 18-S RNA, whereas the normally pulse-labeled 45-S RNA is converted to rRNA regardless of the presence of toyocamycin. We postulate that the altered structure of the 45-S RNA does not permit this conversion. Synthesis of tRNA is not inhibited by toyocamycin, as shown by the ratio of methylation to nucleoside incorporation and the ratio of pseudo-uridine to uridine in the 4-S RNA that was synthesized in the presence of toyocamycin. 2. The concentration of toyocamycin that impairs RNA synthesis is cytotoxic, but permits normal DNA and protein synthesis for 6 h.
UR - https://www.scopus.com/pages/publications/0014421831
U2 - 10.1016/0005-2787(68)90261-X
DO - 10.1016/0005-2787(68)90261-X
M3 - Article
C2 - 5642644
AN - SCOPUS:0014421831
SN - 0005-2787
VL - 157
SP - 33
EP - 42
JO - BBA Section Nucleic Acids And Protein Synthesis
JF - BBA Section Nucleic Acids And Protein Synthesis
IS - 1
ER -